ArticlePloS one2023

Eight versus twelve weeks of sofosbuvir-velpatasvir in treatment-naïve non-cirrhotic patients with chronic hepatitis C virus infection: Study protocol for a multicentric, open labelled, randomized, non-inferiority trial (RESOLVE trial).

Ashish Awasthi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.